CORV - Correvio Pharma's (CORV) CEO Mark Corrigan on Q3 2019 Results - Earnings Call Transcript
Correvio Pharma Corp. (CORV)
Q3 2019 Earnings Conference Call
November 14, 2019 08:30 AM ET
Company Participants
Brendan Payne – Associate Director-Investor Relations and Business Development
Mark Corrigan – Chief Executive Officer
Justin Renz – President and Chief Financial Officer
David Dean – Chief Business Development Officer
Conference Call Participants
Sudan Loganathan – Cantor Fitzgerald
Swayampakula Ramakanth – H.C. Wainwright
David Martin – Bloom Burton
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to Correvio’s Third Quarter 2019 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that